Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / Fund iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer Blackrock
Entity holding fund iShares VII Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF Ticker CUS1(GBX) LSE
ETF Ticker CUSS(USD) LSE
ETF Ticker SXRG(EUR) F
ETF Ticker CSUSS.MI(EUR) CXE
ETF Ticker CSUSSz(USD) CXE
ETF Ticker CUSS.LS(USD) CXE
ETF Ticker CSUSS(EUR) ETF Plus
ETF Ticker CUS1.L(GBP) LSE
ETF Ticker CUSS.L(GBP) LSE

Holdings detail for LFST

Stock Name	Lifestance Health Group Inc
Ticker	LFST(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US53228F1012

Show aggregate LFST holdings

News associated with LFST

LifeStance Health Group (NASDAQ:LFST) vs. DaVita (NYSE:DVA) Financial Review: LifeStance Health Group (NASDAQ:LFST – Get Free Report) and DaVita (NYSE:DVA – Get Free Report) are both mid-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, analyst recommendations, profitability, risk, valuation, institutional ownership and dividends. Institutional and Insider Ownership 85.5% of LifeStance […] - 2025-09-11 02:15:15
Victory Capital Management Inc. Grows Position in LifeStance Health Group, Inc. (NASDAQ:LFST): Victory Capital Management Inc. grew its stake in LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) by 2,599.0% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 370,598 shares of the company’s stock after acquiring an additional 356,867 shares during the quarter. […] - 2025-07-29 04:22:52
BTIG Research Initiates Coverage on LifeStance Health Group (NASDAQ:LFST): BTIG Research started coverage on shares of LifeStance Health Group (NASDAQ:LFST – Free Report) in a report published on Friday, MarketBeat.com reports. The firm issued a buy rating and a $8.00 price target on the stock. A number of other equities analysts also recently commented on the stock. KeyCorp began coverage on shares of LifeStance […] - 2025-07-28 04:22:50
LifeStance Health Group, Inc. (NASDAQ:LFST) Receives $8.50 Consensus Price Target from Brokerages: LifeStance Health Group, Inc. (NASDAQ:LFST – Get Free Report) has earned an average rating of “Moderate Buy” from the six analysts that are currently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, four have assigned a buy rating and one has given a strong buy rating […] - 2025-07-17 04:40:51
LifeStance Health Group, Inc. (NASDAQ:LFST) Shares Sold by Principal Financial Group Inc.: Principal Financial Group Inc. cut its stake in LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) by 5.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,584,850 shares of the company’s stock after selling 203,856 shares during the period. Principal […] - 2025-07-09 05:51:37
Brokerages Set LifeStance Health Group, Inc. (NASDAQ:LFST) PT at $8.50: LifeStance Health Group, Inc. (NASDAQ:LFST – Get Free Report) has earned an average rating of “Moderate Buy” from the six analysts that are currently covering the stock, MarketBeat reports. One analyst has rated the stock with a sell recommendation, four have assigned a buy recommendation and one has given a strong buy recommendation to the […] - 2025-06-20 02:20:16
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Position in LifeStance Health Group, Inc. (NASDAQ:LFST): UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) by 16.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 604,321 shares of the company’s stock […] - 2025-06-04 05:02:51
LifeStance Health Group (NASDAQ:LFST) Raised to Buy at UBS Group: LifeStance Health Group (NASDAQ:LFST – Get Free Report) was upgraded by analysts at UBS Group from a “neutral” rating to a “buy” rating in a research note issued on Tuesday, Marketbeat.com reports. The brokerage currently has a $8.50 target price on the stock. UBS Group’s target price suggests a potential upside of 40.73% from the […] - 2025-05-29 02:30:55
61,247 Shares in LifeStance Health Group, Inc. (NASDAQ:LFST) Bought by D. E. Shaw & Co. Inc.: D. E. Shaw & Co. Inc. purchased a new position in LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) in the fourth quarter, Holdings Channel.com reports. The fund purchased 61,247 shares of the company’s stock, valued at approximately $451,000. Other institutional investors and hedge funds also recently added to or reduced their stakes in the […] - 2025-05-27 04:34:49
Analysts Set LifeStance Health Group, Inc. (NASDAQ:LFST) Price Target at $8.30: LifeStance Health Group, Inc. (NASDAQ:LFST – Get Free Report) has earned an average recommendation of “Moderate Buy” from the six research firms that are presently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell rating, one has assigned a hold rating, three have given a buy rating and one has […] - 2025-05-26 02:48:50
BNP Paribas Financial Markets Takes Position in LifeStance Health Group, Inc. (NASDAQ:LFST): BNP Paribas Financial Markets purchased a new position in shares of LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) during the fourth quarter, HoldingsChannel.com reports. The institutional investor purchased 118,842 shares of the company’s stock, valued at approximately $876,000. A number of other hedge funds and other institutional investors have also recently made changes to […] - 2025-05-22 04:38:48
LifeStance Health Group, Inc. (NASDAQ:LFST) Shares Bought by Invesco Ltd.: Invesco Ltd. lifted its position in shares of LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) by 30.3% during the 4th quarter, HoldingsChannel.com reports. The fund owned 162,146 shares of the company’s stock after acquiring an additional 37,718 shares during the quarter. Invesco Ltd.’s holdings in LifeStance Health Group were worth $1,195,000 as of its […] - 2025-05-02 04:15:05
Analysts Set LifeStance Health Group, Inc. (NASDAQ:LFST) Price Target at $8.30: Shares of LifeStance Health Group, Inc. (NASDAQ:LFST – Get Free Report) have been given a consensus rating of “Moderate Buy” by the six research firms that are covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, three have issued a […] - 2025-05-01 02:50:47
Legal & General Group Plc Boosts Stake in LifeStance Health Group, Inc. (NASDAQ:LFST): Legal & General Group Plc lifted its position in shares of LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) by 4.6% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 134,557 shares of the company’s stock after purchasing an additional 5,917 shares during the […] - 2025-04-28 04:55:10
Renaissance Technologies LLC Acquires 495,300 Shares of LifeStance Health Group, Inc. (NASDAQ:LFST): Renaissance Technologies LLC lifted its holdings in LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) by 421.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 612,800 shares of the company’s stock after acquiring an additional 495,300 shares during the period. Renaissance […] - 2025-04-22 05:02:58
Geode Capital Management LLC Raises Stock Position in LifeStance Health Group, Inc. (NASDAQ:LFST): Geode Capital Management LLC lifted its position in LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) by 0.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,465,471 shares of the company’s stock after acquiring an additional 13,293 shares during the […] - 2025-04-18 04:34:52
LifeStance Health Group, Inc. (NASDAQ:LFST) Holdings Raised by Wellington Management Group LLP: Wellington Management Group LLP increased its stake in LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) by 9.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,276,237 shares of the company’s stock after purchasing an additional 445,796 shares during the quarter. Wellington […] - 2025-04-07 05:26:56
13,053 Shares in LifeStance Health Group, Inc. (NASDAQ:LFST) Acquired by Cibc World Markets Corp: Cibc World Markets Corp purchased a new stake in LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 13,053 shares of the company’s stock, valued at approximately $96,000. A number of other large investors […] - 2025-03-28 06:16:49
Keybank National Association OH Has $420,000 Stake in LifeStance Health Group, Inc. (NASDAQ:LFST): Keybank National Association OH grew its holdings in LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) by 86.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 56,974 shares of the company’s stock after buying an additional 26,412 shares during […] - 2025-03-10 05:53:03
LifeStance Health Group, Inc. (NASDAQ:LFST) Shares Purchased by Rhumbline Advisers: Rhumbline Advisers increased its position in shares of LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) by 4.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 195,581 shares of the company’s stock after acquiring an additional 8,487 shares during […] - 2025-03-05 07:04:57
LifeStance Health Group, Inc. (NASDAQ:LFST) Receives $8.70 Consensus Target Price from Analysts: Shares of LifeStance Health Group, Inc. (NASDAQ:LFST – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the six brokerages that are presently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and four have assigned a buy […] - 2025-03-05 04:40:45

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc LFST holdings

Date	Number of LFST Shares Held	Base Market Value of LFST Shares	Local Market Value of LFST Shares	Change in LFST Shares Held	Change in LFST Base Value	Current Price per LFST Share Held	Previous Price per LFST Share Held
2025-09-26 (Friday)	13,986	USD 75,804	USD 75,804
2025-09-25 (Thursday)	13,986	USD 73,566	USD 73,566	0	USD -2,098	USD 5.25997	USD 5.40998
2025-09-24 (Wednesday)	13,986	USD 75,664	USD 75,664
2025-09-17 (Wednesday)	13,896	USD 71,564	USD 71,564	0	USD -1,112	USD 5.14997	USD 5.22999
2025-09-16 (Tuesday)	13,896	USD 72,676	USD 72,676
2025-09-12 (Friday)	13,806	USD 72,205	USD 72,205
2025-09-11 (Thursday)	13,806	USD 73,724	USD 73,724

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of LFST by Blackrock for IE00B3VWM098

Show aggregate share trades of LFST

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-08-21 SELL -45 5.500* 6.52 Profit of 293 on sale
2025-07-31 BUY 135 3.980* 6.54
2025-06-30 SELL -90 5.170* 6.80 Profit of 612 on sale
2025-06-25 SELL -45 4.950* 6.84 Profit of 308 on sale
2025-06-20 SELL -90 4.830* 6.88 Profit of 619 on sale
2025-05-23 BUY 45 5.490* 7.09
2025-05-19 SELL -45 5.840* 7.13 Profit of 321 on sale
2025-05-15 SELL -135 5.790* 7.16 Profit of 966 on sale
2025-05-12 SELL -45 5.850* 7.19 Profit of 324 on sale
2025-05-09 SELL -45 5.730* 7.20 Profit of 324 on sale
2025-04-30 SELL -45 6.570* 7.26 Profit of 327 on sale
2025-04-24 SELL -90 6.490* 7.29 Profit of 656 on sale
2025-04-17 SELL -45 6.700* 7.34 Profit of 330 on sale
2025-04-15 SELL -135 6.820* 7.35 Profit of 992 on sale
2025-04-14 SELL -135 6.850* 7.36 Profit of 993 on sale
2025-04-09 SELL -180 6.910* 7.37 Profit of 1,327 on sale
2025-04-07 SELL -315 6.510* 7.39 Profit of 2,329 on sale
2025-04-04 SELL -450 6.640* 7.40 Profit of 3,331 on sale
2025-03-31 BUY 45 6.660* 7.43
2025-03-19 SELL -90 6.810* 7.50 Profit of 675 on sale
2025-03-14 SELL -270 6.920* 7.53 Profit of 2,033 on sale
2025-03-13 SELL -90 6.990* 7.54 Profit of 678 on sale
2025-03-12 SELL -1,530 6.850* 7.55 Profit of 11,544 on sale
2025-03-07 SELL -90 7.590* 7.56 Profit of 680 on sale
2025-03-06 SELL -135 7.880* 7.56 Profit of 1,020 on sale
2025-03-03 SELL -45 7.910* 7.53 Profit of 339 on sale
2025-02-28 SELL -270 7.790* 7.53 Profit of 2,033 on sale
2025-02-26 SELL -45 7.510* 7.53 Profit of 339 on sale
2025-02-25 SELL -135 7.520* 7.53 Profit of 1,016 on sale
2025-02-18 BUY 225 8.000* 7.49
2025-02-13 BUY 45 7.990* 7.46
2025-02-12 BUY 45 7.860* 7.45
2025-02-11 BUY 135 7.940* 7.44
2025-02-06 BUY 405 7.980* 7.40
2025-01-27 BUY 45 8.000* 7.26
2024-12-30 BUY 225 7.400* 7.20
2024-12-06 BUY 180 7.340* 7.19
2024-12-05 BUY 45 7.220* 7.19
2024-12-04 BUY 225 7.330* 7.18
2024-11-29 BUY 225 7.520* 7.15
2024-11-27 BUY 180 7.510* 7.12
2024-11-26 BUY 45 7.490* 7.10
2024-11-21 BUY 225 7.310* 7.04
2024-11-20 BUY 135 7.220* 7.03
2024-11-18 BUY 540 7.010* 7.02
2024-11-12 BUY 360 7.400* 7.00
2024-11-08 BUY 225 7.360* 6.97
2024-11-07 BUY 675 7.680* 6.92
2024-11-06 BUY 90 7.130* 6.90
2024-10-31 BUY 45 6.710* 6.96
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-08-21	SELL	-45	5.500*	6.52 Profit of 293 on sale
2025-07-31	BUY	135	3.980*	6.54
2025-06-30	SELL	-90	5.170*	6.80 Profit of 612 on sale
2025-06-25	SELL	-45	4.950*	6.84 Profit of 308 on sale
2025-06-20	SELL	-90	4.830*	6.88 Profit of 619 on sale
2025-05-23	BUY	45	5.490*	7.09
2025-05-19	SELL	-45	5.840*	7.13 Profit of 321 on sale
2025-05-15	SELL	-135	5.790*	7.16 Profit of 966 on sale
2025-05-12	SELL	-45	5.850*	7.19 Profit of 324 on sale
2025-05-09	SELL	-45	5.730*	7.20 Profit of 324 on sale
2025-04-30	SELL	-45	6.570*	7.26 Profit of 327 on sale
2025-04-24	SELL	-90	6.490*	7.29 Profit of 656 on sale
2025-04-17	SELL	-45	6.700*	7.34 Profit of 330 on sale
2025-04-15	SELL	-135	6.820*	7.35 Profit of 992 on sale
2025-04-14	SELL	-135	6.850*	7.36 Profit of 993 on sale
2025-04-09	SELL	-180	6.910*	7.37 Profit of 1,327 on sale
2025-04-07	SELL	-315	6.510*	7.39 Profit of 2,329 on sale
2025-04-04	SELL	-450	6.640*	7.40 Profit of 3,331 on sale
2025-03-31	BUY	45	6.660*	7.43
2025-03-19	SELL	-90	6.810*	7.50 Profit of 675 on sale
2025-03-14	SELL	-270	6.920*	7.53 Profit of 2,033 on sale
2025-03-13	SELL	-90	6.990*	7.54 Profit of 678 on sale
2025-03-12	SELL	-1,530	6.850*	7.55 Profit of 11,544 on sale
2025-03-07	SELL	-90	7.590*	7.56 Profit of 680 on sale
2025-03-06	SELL	-135	7.880*	7.56 Profit of 1,020 on sale
2025-03-03	SELL	-45	7.910*	7.53 Profit of 339 on sale
2025-02-28	SELL	-270	7.790*	7.53 Profit of 2,033 on sale
2025-02-26	SELL	-45	7.510*	7.53 Profit of 339 on sale
2025-02-25	SELL	-135	7.520*	7.53 Profit of 1,016 on sale
2025-02-18	BUY	225	8.000*	7.49
2025-02-13	BUY	45	7.990*	7.46
2025-02-12	BUY	45	7.860*	7.45
2025-02-11	BUY	135	7.940*	7.44
2025-02-06	BUY	405	7.980*	7.40
2025-01-27	BUY	45	8.000*	7.26
2024-12-30	BUY	225	7.400*	7.20
2024-12-06	BUY	180	7.340*	7.19
2024-12-05	BUY	45	7.220*	7.19
2024-12-04	BUY	225	7.330*	7.18
2024-11-29	BUY	225	7.520*	7.15
2024-11-27	BUY	180	7.510*	7.12
2024-11-26	BUY	45	7.490*	7.10
2024-11-21	BUY	225	7.310*	7.04
2024-11-20	BUY	135	7.220*	7.03
2024-11-18	BUY	540	7.010*	7.02
2024-11-12	BUY	360	7.400*	7.00
2024-11-08	BUY	225	7.360*	6.97
2024-11-07	BUY	675	7.680*	6.92
2024-11-06	BUY	90	7.130*	6.90
2024-10-31	BUY	45	6.710*	6.96

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of LFST

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	317,692	0	562,552	56.5%
2025-09-18	266,916	0	826,133	32.3%
2025-09-17	72,635	0	422,082	17.2%
2025-09-16	82,021	0	457,527	17.9%
2025-09-15	443,663	0	1,023,744	43.3%
2025-09-12	126,649	401	321,547	39.4%
2025-09-11	171,643	0	461,797	37.2%
2025-09-10	405,647	100	950,375	42.7%
2025-09-09	306,020	0	1,019,571	30.0%
2025-09-08	681,091	0	1,229,285	55.4%
2025-09-05	189,372	216	412,647	45.9%
2025-09-04	269,899	49,615	563,777	47.9%
2025-09-03	389,664	0	849,179	45.9%
2025-09-02	370,949	0	721,569	51.4%
2025-08-29	380,743	0	783,840	48.6%
2025-08-28	169,228	0	447,022	37.9%
2025-08-27	365,687	0	935,392	39.1%
2025-08-26	256,072	50	486,243	52.7%
2025-08-25	372,786	0	696,444	53.5%
2025-08-22	450,060	1	1,117,293	40.3%
2025-08-21	646,465	0	1,452,989	44.5%
2025-08-20	168,201	0	941,103	17.9%
2025-08-19	279,536	100	1,252,589	22.3%
2025-08-18	200,716	578	591,685	33.9%
2025-08-15	399,406	11,517	899,528	44.4%
2025-08-14	962,034	12	2,354,267	40.9%
2025-08-13	920,623	5,880	2,748,771	33.5%
2025-08-12	208,842	0	1,208,718	17.3%
2025-08-11	282,562	0	1,883,460	15.0%
2025-08-08	382,001	4,611	2,932,912	13.0%
2025-08-07	305,268	1,970	1,764,266	17.3%
2025-08-06	218,802	0	653,854	33.5%
2025-08-05	292,750	0	697,092	42.0%
2025-08-04	633,559	0	992,739	63.8%
2025-08-01	590,337	0	917,727	64.3%
2025-07-31	470,776	0	942,730	49.9%
2025-07-30	427,495	0	927,471	46.1%
2025-07-29	316,947	0	959,996	33.0%
2025-07-28	338,092	0	670,594	50.4%
2025-07-25	354,007	15	683,614	51.8%
2025-07-24	399,654	0	799,376	50.0%
2025-07-23	380,536	5,500	952,839	39.9%
2025-07-22	302,494	0	2,026,199	14.9%
2025-07-21	306,321	11,713	882,238	34.7%
2025-07-18	280,396	4,666	875,429	32.0%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CUS1(GBX) LSE
ETF Ticker	CUSS(USD) LSE
ETF Ticker	SXRG(EUR) F
ETF Ticker	CSUSS.MI(EUR) CXE
ETF Ticker	CSUSSz(USD) CXE
ETF Ticker	CUSS.LS(USD) CXE
ETF Ticker	CSUSS(EUR) ETF Plus
ETF Ticker	CUS1.L(GBP) LSE
ETF Ticker	CUSS.L(GBP) LSE